FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Report of Foreign Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of 1934
For the month of August 2013
Commission File Number: 001-15152
SYNGENTA AG
(Translation of registrant’s name into English)
Schwarzwaldallee 215
4058 Basel
Switzerland
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
|
Form 20-F
|
X
|
Form 40-F
|
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
|
Yes
|
No
|
X
|
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
|
Yes
|
No
|
X
|
Indicate by check mark whether by furnishing the information contained in this Form, the Registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934:
|
Yes
|
No
|
X
|
If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): N/A
|
Re:
|
SYNGENTA AG
|
|
Disclosure:
|
“Appointments to the Executive Committee”
|
Herewith we furnish a press release related to Syngenta AG. The full text of the press release is the following:
# # #
|
Syngenta International AG
|
Media contacts:
|
Analyst/Investor contacts:
|
|||||
|
Media Office
|
Paul Barrett
|
Jennifer Gough
|
|||||
|
CH-4002 Basel
|
Switzerland
|
+41 61 323 2323
|
Switzerland
|
+41 61 323 5059
|
|||
|
Switzerland
|
USA
|
+1 202 737 6521
|
|||||
|
Tel:
|
+41 61 323 2323
|
||||||
|
Fax:
|
+41 61 323 2424
|
Daniel Braxton
|
Lars Oestergaard
|
||||
|
Switzerland
|
+41 61 323 2323
|
Switzerland
|
+41 61 323 6793
|
||||
|
www.syngenta.com
|
USA
|
+1 202 737 6520
|
|||||
Basel, Switzerland, August 30, 2013
Appointments to the Executive Committee
Syngenta announced today two appointments to the Executive Committee.
Patricia Malarkey is appointed Head Research and Development with effect from January 1, 2014. Ms. Malarkey, who began her career in toxicology, has over 15 years’ experience with the company and has held senior scientific positions in crop protection, seeds and biotechnology in both Europe and the United States. She currently heads the research and development activities of the global Lawn and Garden business. Ms. Malarkey will succeed Robert Berendes, Head Business Development, who has been ad interim leader of R&D since October 2012.
Jonathan Seabrook, Head Corporate Affairs, will join the Executive Committee with effect from October 1, 2013. He has more than 10 years’ experience with Syngenta and leads a global team with responsibility for communicating the company’s contribution to society and for managing relationships with a broad range of stakeholders including governments and non-governmental organizations, investors, the media and employees.
Syngenta is one of the world's leading companies with more than 27,000 employees in over 90 countries dedicated to our purpose: Bringing plant potential to life. Through world-class science, global reach and commitment to our customers we help to increase crop productivity, protect the environment and improve health and quality of life. For more information about us please go to www.syngenta.com.
Syngenta – August 30, 2013 / Page 1 of 1
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
SYNGENTA AG
|
||||||
|
Date:
|
August 30, 2013
|
By:
|
/s/ Tobias Meili | |||
|
Name:
|
Dr. Tobias Meili
|
|||||
|
Title:
|
Head Corporate Legal Affairs
|
|||||
|
By:
|
/s/ Brigitte Benz | |||||
|
Name:
|
Brigitte Benz
|
|||||
|
Head Shareholder Services &
Group Administration
|
||||||